<DOC>
	<DOCNO>NCT02329756</DOCNO>
	<brief_summary>The objective study investigate effect tranexamic acid ( TXA ) administration outcome cesarean-hysterectomy woman suspect Morbidly Adherent Placenta ( MAP ; placenta accreta , increta , percreta ) .</brief_summary>
	<brief_title>Tranexamic Acid Adherent Placenta ( TAP )</brief_title>
	<detailed_description>This trial randomize , double blind , placebo control trial quantify effect preoperative administration tranexamic acid estimate blood loss blood product utilization woman undergo cesarean-hysterectomy suspected MAP . Subgroup analyse perform laboratory result ( coagulation study , electrolyte , complete blood count ) , urine output , hemodynamic parameter , return OR continue bleed , post-operative complication ( thromboembolism , wound separation , infection , fever ) , length hospital stay . Eligible patient randomize receive either TXA placebo . Women eligible inclusion identify prenatal course admission hospital prior surgery . They offer participation study appropriate counseling regard equipoise regard TXA use pregnancy , follow question answer period consent , assign study number . A randomization table generate Texas Children 's Hospital Investigational Pharmacy , use balance block 8 , maintain control randomization ensure blind participant clinical investigator . Randomization occur order study medication send paper requisition Texas Children 's Hospital Investigational Pharmacy , randomization number assign correspond study number . Ideally , order sumbitted 24h prior schedule surgery , may submit urgent case call Texas Children 's Clinical Pharmacy , deliver paper requisition 7th Floor Main Pharmacy . The Investigational Pharmacy prepare study medication ( Tranexamic acid I.V . Normal saline placebo ) determine randomization . The medication ( whether study medication placebo ) package identical syrinx . Sealed , opaque envelope available PI assign designee permit unblinding ( link randomization number study number ) event clinical emergency involve study partipant time Investigational Pharmacy close ( night , weekend , holiday ) . Once patient randomize , outcome hospital collect even study medication interrupt actually give .</detailed_description>
	<mesh_term>Placenta Accreta</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Ultrasound and/or MRI diagnose MAPL pregnancy schedule cesarean hysterectomy The responsible clinician substantially uncertain whether use TXA Consent give accord approved procedure Women responsible clinician considers clear indication TXA randomize Prior know thromboembolic event pregnancy Known contraindication TXA ( prior adverse reaction ) Patient unable give adequate consent due emergent cesarean hysterectomy Bleeding prior incision Prior know thromboembolic event Women history acute venous arterial thrombosis include retinal artery/retinal vein occlusion , cerebrovascular accident , myocardial infarction , deep venous thrombosis , pulmonary embolism History decrease renal function , renal cortical disease , significant renal tract disease .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>